BPC-157 and TB-500 are powerful individually. Used together as the Wolverine Stack, they become one of the most comprehensive recovery protocols in the peptide world. Here is why they work better together.
If you have read our individual breakdowns of BPC-157 and TB-500, you already know that both are serious recovery compounds with compelling research behind them. But when people in the peptide space talk about the Wolverine Stack, they are describing something more than just taking two compounds at the same time.
The combination works in a way that is genuinely synergistic. The two peptides target overlapping but distinct mechanisms, cover each other's gaps and together address the recovery process more comprehensively than either does alone.
This article explains why the stack works, how to structure it and who it is most relevant for.
The reference is to the Marvel character Wolverine, who is famous for his near-instantaneous healing ability. While the human results are considerably more modest than fictional regeneration, the name reflects the ambition of the stack: maximising the body's capacity to repair damaged tissue as quickly and completely as possible.
It is a useful mental model, not as literal expectations, but as a description of the direction of effect.
The reason BPC-157 and TB-500 combine so effectively comes down to their complementary mechanisms.
BPC-157's strengths:
- Strong localised effects when injected near an injury site
- Significant angiogenic activity through direct pathway stimulation
- Gut-protective and gut-healing properties
- GH receptor upregulation
- Neurotransmitter system modulation
- Daily dosing maintains consistent local concentrations
TB-500's strengths:
- Systemic reach via actin-binding mechanism
- Cell migration and motility across tissue types
- Upregulation of VEGF for vascular development
- Strong anti-inflammatory action on cytokine pathways
- Longer half-life for sustained circulating levels
- Particularly relevant for cardiac and skeletal muscle
Together, they provide:
The analogy that works well here is construction. BPC-157 is like the site manager: directing activity at the specific location, improving the supply lines and coordinating local resources. TB-500 is like the logistics network: ensuring that repair materials and workers can reach the site from throughout the system.
Acute injury recovery
This is the most straightforward use case. A recent muscle tear, ligament sprain, tendon injury or surgical recovery where the goal is to get back to full function as quickly as possible. The stack addresses the injury from multiple angles: improved blood supply, accelerated cell migration, reduced inflammation and stimulation of fibroblast and tissue cell activity.
Many people who use the Wolverine Stack for acute injuries report noticeably faster return to pain-free function compared to previous injuries of similar severity treated through conventional rest and physiotherapy alone.
Chronic and stubborn injuries
Chronic overuse injuries that have been present for months or years and have not responded adequately to rest, physiotherapy or anti-inflammatory treatment are a significant use case for this stack. Conditions like chronic tendinopathy, recurring joint inflammation and persistent muscle adhesions often involve a failure of the normal healing cycle. The Wolverine Stack addresses the cellular and vascular environment that supports that cycle.
Maintenance for high-volume training
Some athletes use a lower-dose version of the stack on an ongoing basis during periods of particularly high training volume, not to treat a specific injury but to reduce the accumulation of subclinical damage and inflammation that accompanies heavy training loads. This preventive approach is more commonly seen in elite sport and serious amateur contexts.
Post-surgical recovery
Following orthopaedic procedures such as ACL reconstruction, rotator cuff repair or joint replacement, the Wolverine Stack is sometimes used to support the biological side of recovery alongside physiotherapy. The research basis for this application comes from the animal studies on ligament and tendon healing, applied to the post-surgical context where the same tissue types are involved.
The Wolverine Stack is typically structured as follows:
BPC-157
- Dose: 250 to 500mcg per day
- Route: Subcutaneous injection, ideally near the injury site where applicable; abdominal injection for systemic or gut use
- Frequency: Once or twice daily
- Duration: Four to eight weeks
TB-500
- Dose: 5mg per week during a loading phase, reducing to 2 to 2.5mg per week or biweekly during maintenance
- Route: Subcutaneous injection, abdomen or thigh
- Frequency: One to two times per week
- Duration: Six to twelve weeks
The two compounds can be injected in separate syringes at different sites. Some people mix them in the same syringe for convenience, and there is no known chemical incompatibility that prevents this, though separate injections are generally recommended to allow for individualised dosing of each compound.
First two weeks: The most commonly reported early effect is a reduction in localised pain and inflammation, particularly for chronic injuries. Swelling, warmth and tenderness around injury sites often improve during this window.
Weeks three to six: Functional improvement typically becomes more apparent. Range of motion may improve. Strength around the injured area may begin to return. For acute injuries, this is often the window where return-to-training decisions become relevant.
Weeks six to twelve: Consolidation of gains. For chronic or complex injuries, the benefits often continue to build beyond the initial six-week window. Some people run a second course after a break if the injury required more extensive repair.
Individual responses vary considerably. Older injuries, injuries involving poor vascular supply (like tendons) and more severe structural damage will typically take longer to respond than acute soft tissue injuries with good blood supply.
The Wolverine Stack is compatible with most other peptide protocols and does not interfere with the mechanisms of GLP-1 compounds, growth hormone secretagogues or other commonly used peptides. Some common combinations include:
With growth hormone secretagogues (CJC-1295 + Ipamorelin): GH stimulation enhances the anabolic and repair environment systemically, while the Wolverine Stack addresses specific tissue injury. This is a popular combination for athletes looking to optimise both recovery and body composition simultaneously.
With IGF-1 LR3: Given IGF-1's role in muscle protein synthesis and cellular growth, combining it with the Wolverine Stack can provide a particularly comprehensive environment for muscle repair following significant injury or surgery.
In straightforward terms: anyone dealing with an injury that is limiting training, taking longer to heal than expected, or recurring despite conventional treatment.
It is also relevant for anyone training at high volumes who wants to reduce the cumulative toll on connective tissue and joints over time.
If you are new to peptides and have a specific injury driving your interest, the Wolverine Stack is one of the most well-supported starting points in the peptide world. The research is solid, the safety profile is good and the practical reports from athletes and coaches are consistently positive.
Disclaimer: The information in this article is for educational purposes only. STRIATA peptides are research compounds and are not approved medicines. Always consult a qualified healthcare professional before beginning any protocol.
Chat to us on WhatsApp — we'll help you understand your options and find the right compound for your goals.
Chat to Us on WhatsApp →Typically responds within 1 hour during business hours